User profiles for Sylvie Leroy

Sylvie LEROY

- Verified email at chu-nice.fr - Cited by 9105

Sylvie Leroy

- Verified email at sorbonne-universite.fr - Cited by 5244

[PDF][PDF] SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues

…, M Krasnow, M Kuhnemund, R Lafyatis, H Lee, S Leroy… - Cell, 2020 - cell.com
There is pressing urgency to understand the pathogenesis of the severe acute respiratory
syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19. SARS-…

[HTML][HTML] An integrated cell atlas of the lung in health and disease

…, K Inecik, M Jain, TS Kapellos, TM Kole, S Leroy… - Nature Medicine, 2023 - nature.com
Single-cell technologies have transformed our understanding of human tissues. Yet, studies
typically capture only a limited number of donors and disagree on cell type definitions. …

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised …

…, D Lebeaux, B Lefevre, S Leroy… - The Lancet infectious …, 2022 - thelancet.com
Background The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial.
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …

[HTML][HTML] Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics

…, L Mamanova, K Manakongtreecheep, S Leroy… - Nature medicine, 2021 - nature.com
Angiotensin-converting enzyme 2 (ACE2) and accessory proteases (TMPRSS2 and CTSL)
are needed for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cellular entry…

[HTML][HTML] The airway microbiota in cystic fibrosis: a complex fungal and bacterial community—implications for therapeutic management

…, S Monchy, E Fréalle, C Hubans, J Salleron, S Leroy… - PloS one, 2012 - journals.plos.org
Background Given the polymicrobial nature of pulmonary infections in patients with cystic
fibrosis (CF), it is essential to enhance our knowledge on the composition of the microbial …

Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort

…, M Noppen, A Valipour, S Leroy… - European …, 2012 - Eur Respiratory Soc
The Endobronchial Valve for Emphysema Palliation Trial (VENT) was a multi-centre,
prospective, randomised, controlled trial conducted to evaluate the safety and effectiveness of …

A single-cell atlas of the human healthy airways

…, A Paquet, D Pe'er, CH Marquette, S Leroy… - American journal of …, 2020 - atsjournals.org
Rationale: The respiratory tract constitutes an elaborate line of defense that is based on a
unique cellular ecosystem. Objectives: We aimed to investigate cell population distributions …

A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM)

…, NH Ten Hacken, H Fallouh, S Leroy… - American journal of …, 2017 - atsjournals.org
Rationale: Single-center randomized controlled trials of the Zephyr endobronchial valve (EBV)
treatment have demonstrated benefit in severe heterogeneous emphysema. This is the …

Electromagnetic navigation diagnostic bronchoscopy for small peripheral lung lesions

D Makris, A Scherpereel, S Leroy… - European …, 2007 - Eur Respiratory Soc
The present study prospectively evaluated the diagnostic yield and safety of electromagnetic
navigation-guided bronchoscopy biopsy, for small peripheral lung lesions in patients where …

Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial

…, R Kessler, V Jounieaux, L Thiberville, S Leroy… - Jama, 2016 - jamanetwork.com
Importance Therapeutic options for severe emphysema are limited. Lung volume reduction
using nitinol coils is a bronchoscopic intervention inducing regional parenchymal volume …